Literature DB >> 7543821

Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.

L Lanza1, L Peirano, O Bosco, P Contini, G Filaci, M Setti, F Puppo, F Indiveri, M Scudeletti.   

Abstract

The relative potency of interferon alpha (IFN alpha), interferon beta (IFN beta), and interferon gamma (IFN gamma) in inducing the expression of HLA class I antigens, as well as their capacity to counteract the inhibition induced by glucocorticoid hormones on HLA class I antigen expression, were analysed in the human melanoma cell line M14, both at membrane and at mRNA level. The data obtained indicate that (a) IFN enhance with different potency (IFN gamma > IFN beta > IFN alpha) the expression of HLA class I antigens in M14 cells, (b) prednisone inhibits HLA class I antigen expression, (c) glucocorticoid hormones, when associated with IFN alpha or IFN gamma, inhibit the HLA class I enhancement induced by IFN alone, and, finally, (c) the association between 1 microM prednisone or 1 microM deflazacort and IFN beta seems to potentiate the enhancing capacity of IFN on the expression of HLA class I molecules at the mRNA level. These findings, if confirmed, might indicate that IFN and glucocorticoid hormones are not mutually exclusive in the management of human melanoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543821     DOI: 10.1007/bf01788956

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

Review 1.  Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system.

Authors:  N Tanaka; T Taniguchi
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

Review 2.  New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.

Authors:  M Scudeletti; L Castagnetta; B Imbimbo; F Puppo; I Pierri; F Indiveri
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Glucocorticoids enhance the gamma-interferon augmentation of human monocyte immunoglobulin G Fc receptor expression.

Authors:  M T Girard; S Hjaltadottir; A N Fejes-Toth; P M Guyre
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

Review 4.  Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.

Authors:  K Tanaka; T Yoshioka; C Bieberich; G Jay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

Review 5.  Control of gene expression by glucocorticoid hormones.

Authors:  G G Rousseau
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

6.  Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells.

Authors:  R L Friedman; S P Manly; M McMahon; I M Kerr; G R Stark
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

7.  Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells.

Authors:  L Y Pan; D B Mendel; J Zurlo; P M Guyre
Journal:  J Immunol       Date:  1990-07-01       Impact factor: 5.422

8.  A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.

Authors:  K Imai; B S Wilson; A Bigotti; P G Natali; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1982-05       Impact factor: 13.506

9.  Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils.

Authors:  G Marone; C Stellato; A Renda; A Genovese
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages.

Authors:  C A Salkowski; S N Vogel
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

View more
  3 in total

Review 1.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

Review 2.  Understanding the Immune-Stroma Microenvironment in B Cell Malignancies for Effective Immunotherapy.

Authors:  Benedetta Apollonio; Nikolaos Ioannou; Despoina Papazoglou; Alan G Ramsay
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

3.  A Well-Controlled Experimental System to Study Interactions of Cytotoxic T Lymphocytes with Tumor Cells.

Authors:  Natalie J Neubert; Charlotte Soneson; David Barras; Petra Baumgaertner; Donata Rimoldi; Mauro Delorenzi; Silvia A Fuertes Marraco; Daniel E Speiser
Journal:  Front Immunol       Date:  2016-08-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.